Majid Pirestani

9PUBLICATIONS
12CO-AUTHORS
Biomolecular modelling and designLivestock cloningMedical infection agents (incl. prions)Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 28, 2026
Reprogramming parasitic signatures into anticancer peptide candidates: in silico discovery of Leishmania major-derived peptides.

|Mar 05, 2025
Designing and Evaluation of a Plasmid Encoding Immunogenic Epitopes From Echinococcus granulosus Eg95-1-6, P29, and GST Against Hydatid Cyst in BALB/c Mice.

Sasan Khazaei, Abdolhossein Dalimi, Majid Pirestani

|Feb 24, 2025
Detection of Acanthamoeba Harboring Campylobacter jejuni Endosymbionts in Hospital Environments of Markazi Province, Iran.

Alireza Mohammadi, Abdolhossein Dalimi, Fatemeh Ghaffarifar

|Oct 02, 2024
Enhancement of apoptosis in Caco-2, Hep-G2, and HT29 cancer cell lines following exposure to Toxoplasma gondii peptides.

Firooz Shahrivar, Javid Sadraei, Majid Pirestani

|Sep 18, 2023
The Frequency of Intestinal Parasitic Infections in COVID-19 Patients: A Case-Control Study in Tehran, Capital of Iran.

Ali Taghipour, Majid Pirestani, Ramin Hamidi Farahani

|Aug 17, 2023
Thymoquinone Effect on Leishmania tropica/infantum and Leishmania-Infected Macrophages.

Amir KarimiPourSaryazdi, Mohammad Mahdi Jafari, Majid Pirestani

Pageof 2

Frequent Collaborators

4 joint publications

Abdolhossein Dalimi

4 joint publications

Fatemeh Ghaffarifar

2 joint publications

Ali Dalir Ghaffari

1 joint publications

Hamidreza Majidiani